Human-AI Collaborative Intelligence for Improving Fetal Flow Management
NCT ID: NCT06371859
Last Updated: 2024-05-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
92 participants
INTERVENTIONAL
2024-04-29
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Objectives:
1. To develop an interpretable model for commonly used Doppler flows, specifically the Pulsatility Index (PI) of the umbilical artery (UA) and middle cerebral artery (MCA), with the aim to provide quality feedback on Doppler spectrum images and suggest potential gate placements.
2. To test the effects of providing Explainable AI (XAI)-feedback for clinicians compared with no feedback on their accuracy in ultrasound interpretation and management.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AI Support in Novice's Decision-making for Ultrasound Fetal Weight Estimation
NCT06232187
A Comparative Study of AI Methods for Fetal Diagnostic Accuracy in Ultrasound
NCT06268392
The Study Aims to Improve the Accuracy of Detecting Spina Bifida During Early Ultrasound Scans. to Achieve This, an AI Model Has Been Developed to Provide Feedback About the Presence of Spina Bifida. a RCT Has Been Designed to Compare the Effectiveness of AI Feedback with No AI Feedback.
NCT06566014
Assessing Demographic Biases in Deep Learning Model for Fetal Growth Estimation in Clinical Practice. Patients Eligible for Inclusion Are Women with a Gestational Age Between 24-42 Weeks Undergoing a Third-trimester Growth Scan. the Image Data from the Scan Are Used to Calculate Fetal Weight.
NCT06314178
Artificial Intelligence Algorithm for the Screening of Abnormal Fetal Brain Findings at First Trimester Ultrasound Scan
NCT05790473
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The study's objectives are:
1. To develop an interpretable model for commonly used Doppler flows, specifically the Pulsatility Index (PI) of the umbilical artery (UA) and middle cerebral artery (MCA), with the aim to provide quality feedback on Doppler spectrum images and suggest potential gate placements.
2. To test the effects of providing Explainable AI (XAI)-feedback for clinicians compared with no feedback on their accuracy in ultrasound interpretation and management.
All participants will be instructed to provide gate placement for flow images of the umbilical artery and the MCA, and to evaluate the quality of the resulting flow curves. Each participant will be required to evaluate a total of 40 unique images (10 flow images for UA and MCA, 10 spectral doppler images for UA and MCA, respectively). From the four groups (UA-flow, UA-spectrum, MCA-flow \& MCA-spectrum) the investigators will provide matched sets of 40 images that are provided to participants, who are matched for their level of experience within each hospital (PGY 1-2; PGY 3-5; board certified Obstetricians). For flow images, the participants will be instructed to identify the most appropriate gate placement. For the spectral flow curves, participants will be asked to evaluate whether the flow curves were of sufficient quality to inform medical management decisions.
The inclusions criteria for MCA and UA images will be images taken from the third trimester (\>= week 28).
Study Design: Randomized controlled trial
Data Source: 1840 unique ultrasound scans including umbilical artery (UA) and middle cerebral artery (MCA) measurements. The 1840 unique images includes: 460 images of UA-flow images, 460 UA-spectrum images, 460 MCA-flow images and 460 MCA-spectrum images.
Participants: 92 clinicians with varying competence levels across four different university hospitals.
Intervention: XAI feedback on MCA/UA Doppler spectral curves and gate placement suggestions.
Control Group: No XAI feedback.
Procedure: Clinicians will be divided into two groups of 46 each, matched for experience levels across hospitals. The control group will place a gate on MCA/UA images and evaluate the Doppler spectrum without AI feedback, while the intervention group will perform the same tasks with access to AI feedback.
Outcome Measures: The participants' responses in the two groups are reviewed by two fetal medicine sonographers who evaluate the participants' answers independently of each other. In a disagreement, the two sonographers reach a consensus after discussion.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
"XAI feedback on MCA/UA Doppler spectral curves and gate placement suggestions"
The XAI feedback group will place a gate on MCA/UA images and evaluate the Doppler spectrum with AI feedback.
N=46 clinicians (Clinicians will be divided into two groups (XAI feedback \& No XAI feedback groups) of 46 each, matched for experience levels across hospitals)
"XAI feedback on MCA/UA Doppler spectral curves and gate placement suggestions"
This study includes 1840 ultrasound images, split into UA and MCA flow and spectrum images, each duplicated for a total of 3680 images to compare explainable AI (XAI) feedback vs. no feedback. The investigators will provide matched sets of 40 images (one for the XAI group and one for the non-XAI group) to participants. Participants are matched based on their level of experience within each hospital (Resident physicians, obstetricians, and gynecologists with obstetric ultrasound experience).
All participants are instructed to place gates on the flow images of the umbilical artery and the middle cerebral artery and to assess the quality of the resulting flow curves. Specifically, for flow images, participants must identify the most appropriate gate placement. For spectral flow curves, they are to decide if the curves are of sufficient quality to guide medical management decisions.
"No XAI feedback"
The control group will place a gate on MCA/UA images and evaluate the Doppler spectrum without AI feedback.
N=46 clinicians (Clinicians will be divided into two groups (XAI feedback \& No XAI feedback groups) of 46 each, matched for experience levels across hospitals)
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
"XAI feedback on MCA/UA Doppler spectral curves and gate placement suggestions"
This study includes 1840 ultrasound images, split into UA and MCA flow and spectrum images, each duplicated for a total of 3680 images to compare explainable AI (XAI) feedback vs. no feedback. The investigators will provide matched sets of 40 images (one for the XAI group and one for the non-XAI group) to participants. Participants are matched based on their level of experience within each hospital (Resident physicians, obstetricians, and gynecologists with obstetric ultrasound experience).
All participants are instructed to place gates on the flow images of the umbilical artery and the middle cerebral artery and to assess the quality of the resulting flow curves. Specifically, for flow images, participants must identify the most appropriate gate placement. For spectral flow curves, they are to decide if the curves are of sufficient quality to guide medical management decisions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Slagelse Hospital
OTHER
Technical University of Denmark
OTHER
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zahra Bashir
Ph.d.student, medical doctor and primary investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rigshospitalet
Copenhagen, Capital Region of Denmark, Denmark
Slagelse Hospital
Slagelse, Region Sjælland, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Zahra Bashir, MD
Role: primary
Zahra Bashir, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3-3031-2915/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.